Work

Pharmaceutical Manufacturer Kickback Resolutions and Associated Financial Penalties, 2000-2025

Year: 2026

Type: article

Abstract: This cross-sectional study investigates the size of financial penalties levied by the US government against pharmaceutical companies accused of violating the Anti-Kickback Statute.

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2026.1735

Authors: Tobias Liu, Joseph S. Ross, Christopher J. Morten, Reshma Ramachandran

Institutions: Yale University, New York University

Language: English

Topic: Pharmaceutical industry and healthcare

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Peace, justice, and strong institutions

Open Access status: gold

Estimated APC paid: $3,000

Funders: Greenwall Foundation, Arnold Ventures

OpenAlex ID: W7135240968

FWCI:

Cites: 4

Cited by:

Related to: